INSUBCONTINENT EXCLUSIVE:
Sun Pharma shares jumped as much as 3.15% on the BSE after the earnings announcementSun Pharmaceutical Industries on Thursday reported a net
profit of Rs 1,064.09 crore for the quarter ended September 30
The drug major had posted a net loss of Rs 269.60 crore for the corresponding period a year ago
In a regulatory filing, Sun Pharma said its revenue from operations came in at Rs 8,123.35 crore in the second quarter of current financial
year, as against Rs 6,937.63 crore in the year-ago period
Shares in Sun Pharma rose more than 3 per cent during the session."Our Q2 and H1 performance demonstrates sustained growth momentum and is
in-line with our full-year guidance
We continue to focus on cost savings and efficiency improvement to align our generic business with the changing industry dynamics," said
Dilip Shanghvi, Managing Director, Sun Pharmaceutical Industries.Its operating profit - or the earnings before interest, tax, depreciation
and amortization (EBITDA) - came in at't Rs
1,616 crore in the September quarter, marking an increase of 12 per cent over the year-ago period.Sales of Sun Pharma's branded
formulations in the country rose 35 per cent to Rs 2,515 crore in the July-September period, and accounted for 31.6 per cent of total
consolidated sales, Sun Pharma said in a press release.Its US finished dosage sales stood flat at $339 million, Sun Pharma said.On the BSE,
the Sun Pharma stock jumped as much as 3.15 per cent to Rs 441.00 apiece after the earnings announcement
At 2:56 pm, Sun Pharma shares traded 2.70 per cent higher at Rs 439.10 apiece on the bourse, outperforming the benchmark Sensex index which
was up 0.32 per cent.Get Breaking news, live coverage, and Latest News from India and around the world on TheIndianSubcontinent.com
Catch all the Live TV action on TheIndianSubcontinent 24x7 and TheIndianSubcontinent India
Like us on Facebook or follow us on Twitter and Instagram for latest news and live news updates.
